WIERENGA; Wendell

Patent Applications and Registrations

Patent applications and USPTO patent grants for WIERENGA; Wendell.The latest application filed is for "method for treating intestinal diseases presenting at least one inflammatory component".

Company Profile

1.18.5

WIERENGA; Wendell - Rancho Santa Fe CA
Wierenga; Wendell - Ann Arbor MI
Wierenga; Wendell - Oshtemo MI
Wierenga; Wendell - Kalamazoo MI
Wierenga; Wendell - Oshtemo Township Kalamazoo County

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Treating Intestinal Diseases Presenting At Least One Inflammatory Component App 20200163888 - PROEHL; Gerald Thomas ; et al.	2020-05-28
Method For Treating Intestinal Diseases Presenting At Least One Inflammatory Component App 20150017239 - Moro; Luigi ; et al.	2015-01-15
Method For Treating Intestinal Diseases Presenting At Least One Inflammatory Component App 20140187517 - PROEHL; Gerald Thomas ; et al.	2014-07-03
Method For Treating Intestinal Diseases Presenting At Least One Inflammatory Component App 20130225537 - PROEHL; Gerald Thomas ; et al.	2013-08-29
Method For Treating Intestinal Diseases Presenting At Least One Inflammatory Component App 20130209559 - PROEHL; Gerald Thomas ; et al.	2013-08-15
N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents Grant 5,491,172 - Lee , et al. February 13, 1	1996-02-13
1,2,8,8a-tetrahydrocyclopropa (C) pyrrolo [3,2-e)]-indol-4(5H)-ones and related compounds Grant 4,978,757 - Kelly , et al. December 18, 1	1990-12-18
.DELTA..sup.9(11) -angiostatic steroids Grant 4,975,537 - Aristoff , et al. December 4, 1	1990-12-04
11a-hydroxy steroid diester Grant 4,948,533 - Braughler , et al. August 14, 1	1990-08-14
1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds Grant 4,912,227 - Kelly , et al. March 27, 1	1990-03-27
Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments Grant 4,771,042 - Braughler , et al. September 13, 1	1988-09-13
Novel compounds and process for treating hypertension Grant 4,593,096 - Wierenga , et al. June 3, 1	1986-06-03
Use of 6-aryluracils as antiinflammatory and antiarthritic agents Grant 4,593,030 - Skulnick , et al. June 3, 1	1986-06-03
Process for therapeutic treatment Grant 4,590,211 - Voorhees , et al. * May 20, 1	1986-05-20
Substituted phenylalkyl compounds Grant 4,496,492 - Wierenga January 29, 1	1985-01-29
Process for treating hypertension Grant 4,460,589 - Wierenga , et al. * July 17, 1	1984-07-17
1,2,8,8a-Cyclopropa[c]benzo[1,2,-b:-4,3-b']dipyrrol-4(5H)-ones Grant 4,424,365 - Wierenga January 3, 1	1984-01-03
Preparation of an intermediate for N-(methylsulfonyl)-1,2,8,8a-cyclopropa[c][1,2-b:-4,3-b']dipyrol-4(5H)-on e Grant 4,423,230 - Wierenga December 27, 1	1983-12-27
Process for preparing N-(methyl-sulfonyl)-1,2,8,8a-cyclopropa[c]benzo[1,2-b:4,3-b']dipyrrol-4( 5H)-one Grant 4,423,228 - Wierenga December 27, 1	1983-12-27
Antibiotic CC-1065 indoline intermediates Grant 4,413,132 - Wierenga November 1, 1	1983-11-01
Process for treating hypertension Grant 4,308,272 - Wierenga , et al. December 29, 1	1981-12-29
Process for therapeutic treatment Grant 4,235,887 - Voorhees , et al. November 25, 1	1980-11-25
2,2'-Anhydrotriazine nucleosides and process for preparing the same Grant 4,140,850 - Wierenga February 20, 1	1979-02-20

Company Registrations

SEC

0001239956

WIERENGA WENDELL

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.